Market Place
Sourcing Support
Sanofi, RadioMedix, Orano Med Partner On Radioligand For Rare Cancers
12 Sep 2024 //
GLOBENEWSWIRE
RadioMedix & Orano receive FDA Breakthrough Therapy Designation for AlphaMedixTM
12 Feb 2024 //
BUSINESSWIRE
RadioMedix Inc. Announces the Acquisition of its 225Ac-PSMA I&T program
15 Feb 2023 //
GLOBENEWSWIRE
RadioMedix and Vect-Horus announce first dosing of Glioblastoma Multiforme
15 Nov 2022 //
GLOBENEWSWIRE
RadioMedix announces a $40m Series A for the advancement
07 Oct 2022 //
GLOBENEWSWIRE
Radiomedix, Orano Med Initiate Phase II Multi-Center Trial of Alphamedix
03 Jan 2022 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.